Search results for: 'path development'

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides actionable insights across new developments in prebiotics, immunology, oncology, cell and gene therapies, antibody therapies, and precision medicine approaches. The TOE also encompasses technology advances across the use of AI and ML in drug discovery a...

11 Aug 2025  |  Global  |  Market Research

Advanced Wound Care Industry Driving Transformational Growth by Developing Digital Wound Management Solutions, Global, 2024–2030

Advanced Wound Care Industry is Experiencing Transformational Growth Due to the Development of Digital Wound Management Solutions

Infographics

×

The advanced wound care management industry is rapidly evolving with the emergence of sensor-based wearables, handheld wound scanners, disposable NPWT devices, AI-powered tools, digital wound assessment devices, and bioengineered skin substitutes. Advanced dressings—such as silicone and antimicrobial types—are also gaining traction, increasingly re...

This Frost Radar™ analyzes the competitive landscape of the antibody-drug conjugate (ADC) contract development and manufacturing organization (CDMO) market. Companies provide the foundational manufacturing and development services for what has become one of the most dynamic and valuable therapeutic modalities in oncology. The success of the ADC rev...

This report is a thorough examination of the current and future face of therapy for neurodegenerative diseases, such as Alzheimer's and Parkinson's. It articulates important growth drivers (e.g., precision medicine, AI paradigm for diagnostics, and the transformational megatrends of aging populations) and barriers they will face (e.g., the nature o...

This study explores the transformative potential of organoid technologies in advancing cancer research, precision medicine, and drug discovery. Organoids—3D cell culture systems derived from patient tumors—preserve tumor heterogeneity and provide physiologically relevant models for studying cancer biology, therapeutic response, and resistance mecha...

The discovery of new drug targets for diseases with unmet medical needs has long been hindered by the complexity of processing and interpreting massive volumes of biological data. The increasing volume and veracity of clinical and research data compels the use of enabling tools and technologies, such as cloud computing, AI, machine learning, natura...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) covers insights across biomanufacturing, targeted drug delivery, imaging, precision medicine and biologics innovations.The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and ...

Vital signs monitoring devices that support remote monitoring are growing rapidly due to the increasing need for home care and chronic disease management solutions. Moreover, the increasing workload on clinicians and nurses is driving demand for continuous vital signs monitoring solutions in hospital settings. Clinical-grade wearables are dominatin...

In the rapidly evolving landscape of 2025, where technological advancements are accelerating, the ability to identify, invest in, and leverage these advancements is becoming increasingly critical for organizations aiming to maintain industry leadership and ensure sustainable growth. Recognizing this imperative, Frost & Sullivan introduces (launches...